$Primega Group (PGHL.US)$ The information disclosed under...
The information disclosed under this Form 6-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
Appointment of Independent Non-Executive Director
The board (“Board”) of directors of Primega Group Holdings Limited (the “Company”) announces that Mr. Zhao Yong (“Mr. Zhao”) will be appointed as independent non-executive director with effect from December 19, 2024. The Board has determined that Mr. Zhao is an independent director and meets the applicable director’s independence requirements.
Mr. Zhao, aged 50, has served as the director of Jiuzhou Kanglian Technology Development (Beijing) Co., Ltd., a company based in the People’s Republic of China which is primarily engaged in the manufacturing and sale of medical equipment, since January 2008 where he is tasked with, amongst others, the general management of the operations of the company.
The Board believes Mr. Zhao will bring abroad rich management experience to the Company and would like to take this opportunity to welcome Mr. Zhao on joining the Board.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
72637476 : so this is a good thing?
Mutawakkil OP 72637476 : I dont know but this is the answer from chatgpt:
The information in Form 6-K regarding the appointment of Mr. Zhao Yong as an Independent Non-Executive Director at Primega Group Holdings Limited (PGHL) is positive news. Here are the reasons:
1. Appointment of an Independent Non-Executive Director
Independent directors play a crucial role in ensuring transparent and high-integrity corporate governance.
Mr. Zhao is considered to meet the qualifications as an independent director, which indicates that he has a good reputation and is free from conflicts of interest.
2. Experience and Expertise of Mr. Zhao
He has over 16 years of experience as a director in a medical technology company in China.
His experience in managing large-scale company operations demonstrates his capability in strategic decision-making and his understanding of the business world.
3. Impact on the Company
His appointment can add value to PGHL through more strategic insights and his experience in the technology and medical sectors.
This also signals to investors that the company is committed to strengthening its corporate governance and bringing in new expertise.
Conclusion
This news has a positive impact on PGHL because the appointment of an experienced independent director can enhance investor confidence in the company. It also demonstrates that PGHL is serious about strengthening its market position and ensuring compliance with high standards of corporate governance.
If you are an investor, this could improve the company’s future prospects.